PT100086A - Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos - Google Patents

Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos

Info

Publication number
PT100086A
PT100086A PT100086A PT10008692A PT100086A PT 100086 A PT100086 A PT 100086A PT 100086 A PT100086 A PT 100086A PT 10008692 A PT10008692 A PT 10008692A PT 100086 A PT100086 A PT 100086A
Authority
PT
Portugal
Prior art keywords
epoxes
dihydroxyprepen
butilidenodioxi
16alfa
17alfa
Prior art date
Application number
PT100086A
Other languages
English (en)
Other versions
PT100086B (pt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT100086A publication Critical patent/PT100086A/pt
Publication of PT100086B publication Critical patent/PT100086B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT100086A 1991-02-04 1992-02-03 Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos PT100086B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids

Publications (2)

Publication Number Publication Date
PT100086A true PT100086A (pt) 1994-05-31
PT100086B PT100086B (pt) 1999-06-30

Family

ID=20381806

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100086A PT100086B (pt) 1991-02-04 1992-02-03 Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos

Country Status (40)

Country Link
US (2) US5674861A (pt)
EP (1) EP0570454B1 (pt)
JP (1) JPH06505232A (pt)
KR (1) KR100216720B1 (pt)
CN (3) CN1034868C (pt)
AP (1) AP366A (pt)
AT (1) ATE178611T1 (pt)
BG (1) BG62211B1 (pt)
CA (1) CA2103924A1 (pt)
CZ (1) CZ281685B6 (pt)
DE (1) DE69228870T2 (pt)
DK (1) DK0570454T3 (pt)
DZ (1) DZ1553A1 (pt)
EE (1) EE03111B1 (pt)
ES (1) ES2133315T3 (pt)
FI (1) FI933450A0 (pt)
GR (1) GR3030657T3 (pt)
HK (1) HK1010733A1 (pt)
HU (1) HU218275B (pt)
IE (1) IE920166A1 (pt)
IL (1) IL100532A (pt)
IS (1) IS1601B (pt)
MA (1) MA22406A1 (pt)
MX (1) MX9200324A (pt)
NO (1) NO304073B1 (pt)
NZ (1) NZ241210A (pt)
PH (1) PH31284A (pt)
PL (1) PL170000B1 (pt)
PT (1) PT100086B (pt)
RO (1) RO111195B1 (pt)
RU (1) RU2111212C1 (pt)
SE (1) SE9100341D0 (pt)
SG (1) SG52557A1 (pt)
SI (1) SI9210065B (pt)
SK (1) SK281801B6 (pt)
TN (1) TNSN92007A1 (pt)
UA (1) UA41267C2 (pt)
WO (1) WO1992013872A1 (pt)
YU (1) YU48892B (pt)
ZA (1) ZA92233B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
CA2152374A1 (en) * 1993-01-08 1994-07-21 Ralph Lennart Brattsand Novel colon- or ileum-specific steroid derivatives
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
IT1291288B1 (it) 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
BR0212767A (pt) * 2001-09-25 2004-10-13 Pharmacia & Upjohn Comapny Transacetalização estereosseletiva de acetonida esteriodal c-22
CN100577681C (zh) 2002-07-08 2010-01-06 葛兰素伊斯特拉齐瓦基森塔萨格勒布公司 用于治疗炎性疾病和病症的新化合物、组合物和方法
WO2004005313A2 (en) 2002-07-08 2004-01-15 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
AU2003265576A1 (en) * 2002-08-23 2004-03-11 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
DE602005018672D1 (de) 2004-10-27 2010-02-11 Glaxosmithkline Zagreb Konjugate mit entzündungshemmender aktivität
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007008155A1 (en) * 2005-07-11 2007-01-18 Astrazeneca Ab New combination 1
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (pt) * 1972-05-19 1975-08-18 Bofors Ab
SE378110B (pt) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
CN1060471A (zh) * 1985-04-04 1992-04-22 得拉科公司 新的16，17-缩醛取代雄甾烷-17β-酮类的制备方法
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters

Also Published As

Publication number Publication date
CN1064079A (zh) 1992-09-02
ES2133315T3 (es) 1999-09-16
ZA92233B (en) 1992-10-28
CA2103924A1 (en) 1992-08-05
YU6592A (sh) 1995-01-31
IL100532A0 (en) 1992-09-06
CN1034868C (zh) 1997-05-14
EP0570454A1 (en) 1993-11-24
NO932761D0 (no) 1993-08-02
BG62211B1 (bg) 1999-05-31
WO1992013872A1 (en) 1992-08-20
EP0570454B1 (en) 1999-04-07
HU9302244D0 (en) 1993-10-28
AU1230792A (en) 1992-09-07
NZ241210A (en) 1993-08-26
YU48892B (sh) 2002-10-18
UA41267C2 (uk) 2001-09-17
DE69228870T2 (de) 1999-08-19
CZ281685B6 (cs) 1996-12-11
HK1010733A1 (en) 1999-06-25
TNSN92007A1 (fr) 1993-06-08
EE03111B1 (et) 1998-08-17
JPH06505232A (ja) 1994-06-16
SE9100341D0 (sv) 1991-02-04
PH31284A (en) 1998-07-06
KR100216720B1 (ko) 1999-10-01
HU218275B (en) 2000-07-28
SK281801B6 (sk) 2001-08-06
CN1140178A (zh) 1997-01-15
DZ1553A1 (fr) 2002-02-17
US5939409A (en) 1999-08-17
HUT64973A (en) 1994-03-28
FI933450A (fi) 1993-08-03
PT100086B (pt) 1999-06-30
GR3030657T3 (en) 1999-10-29
ATE178611T1 (de) 1999-04-15
CN1140059A (zh) 1997-01-15
SI9210065B (en) 2001-12-31
RO111195B1 (ro) 1996-07-30
IS1601B (is) 1996-10-18
NO304073B1 (no) 1998-10-19
PL170000B1 (pl) 1996-10-31
MA22406A1 (fr) 1992-10-01
SG52557A1 (en) 1998-09-28
IE920166A1 (en) 1992-08-12
CN1052155C (zh) 2000-05-10
CN1058724C (zh) 2000-11-22
MX9200324A (es) 1992-09-01
AP366A (en) 1994-10-21
BG97971A (bg) 1994-04-29
CZ149693A3 (en) 1994-03-16
DE69228870D1 (de) 1999-05-12
SK79693A3 (en) 1994-03-09
AU661471B2 (en) 1995-07-27
NO932761L (no) 1993-08-02
SI9210065A (en) 1995-02-28
AP9200353A0 (en) 1992-01-31
IS3808A (is) 1992-08-05
FI933450A0 (fi) 1993-08-03
DK0570454T3 (da) 1999-10-18
RU2111212C1 (ru) 1998-05-20
IL100532A (en) 1996-05-14
US5674861A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
PT100086A (pt) Epimeros de esteroides de 16alfa, 17alfa-butilidenodioxi-11beta, 21-di-hidroxipregn-4-eno-3,20-diona fluoro-substituidos
DE69407978D1 (de) Androstenderivate
DE69017938D1 (de) Steroid-Derivate.
NL300035I1 (nl) Gesubstitueerde thiahzolidinedionderivaten.
FI932594A (fi) Antenn med justerbar loblutning
ATA75293A (de) Indolderivate
NO931117D0 (no) Steroidderivater
DE69329894D1 (de) Arylamidderivate
MX9205003A (es) Derivados novedosos de benzopirano.
DK210689D0 (da) Steroidderivater
ITMI911432A0 (it) Steroidi 3-carbossi 17b - sostituiti insaturi
ATE172738T1 (de) Substituierte 6-aza-androstenone
FI952804A (fi) Substituoidut bentsatsepinonit
MX9200748A (es) Formulaciones de esteroides. formulaciones de esteroides.
FI905746A0 (fi) Steroider.
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9204370A (es) Derivados de pirazol.
MX9201931A (es) Nuevos derivados de tiazol.
MX9205973A (es) Derivados de benzo-isoquinolinas.
FI934935A (fi) Maetcell foer elektrokinetisk potential
FR2684283B1 (fr) Panneau pare-douche en coquille.
DK0718273T3 (da) Ethyl-6-formyloxy-4-hexenoat
KR930000067U (ko) 팝콘기
DE59308427D1 (de) Unterwäsche

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19931027

FG3A Patent granted, date of granting

Effective date: 19990317

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20030930